CIK 0001795091 · <br>Emerging growth company
OS Therapies Inc
Sign in to watch- Ticker
- OSTX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825118368
- Phone
- 410-297-7793
- Business address
- 15825 SHADY GROVE ROAD, SUITE 135, ROCKVILLE, MD, 20850
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 3 Insider Initial Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- D Other Notice of Sales of Unregistered Securities
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 16,720 shares at $6.74 ($112,609)
- 8-K Event Other events
- 4 Conversion 10% owner acquired 1,766,927 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 8 of 13 · 247 filings